Hillstream BioPharma, Inc.
Hillstream BioPharma, Inc. (HILS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HILS · as of Jun 9, 2026
Key Statistics
Explore Hillstream BioPharma, Inc. Data
hils stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
hils competitorsHILS
APTO
BCEL
CYTO
GMDA
GRTSStock Performance
Full HistoryAbout Hillstream BioPharma, Inc.
Hillstream BioPharma, Inc. is a pre-clinical stage biotechnology firm committed to creating groundbreaking therapeutic options. Its core mission is to exploit ferroptosis, an anti-cancer pathway that …
what is hillstream biopharma, inc. · hils stock overview · hillstream biopharma, inc. company profile · who is hillstream biopharma, inc. ceo · hils NASDAQ · hillstream biopharma, inc. headquarters · hillstream biopharma, inc. business segments
About Stock Overview & Key Data
Hillstream BioPharma, Inc. (HILS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 12, 2022. As of the latest trading session, HILS stock price is $0.24, with a market capitalization of $4.2M. The stock has returned -63.65% over the past 12 months and -30.50% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Hillstream BioPharma, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Hillstream BioPharma, Inc. reported revenue of — and net income of -$35.9M. For detailed data — including Hillstream BioPharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hillstream BioPharma, Inc. (HILS) stock price is $0.24. The stock is traded on NASDAQ under the ticker symbol HILS. The 52-week range is $0.17 – $2.65.